{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:26:58Z","timestamp":1793384818453,"version":"4.5.0"},"reference-count":270,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq\/Brazil","doi-asserted-by":"publisher","award":["401511\/2014-6"],"award-info":[{"award-number":["401511\/2014-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG\/Brazil","doi-asserted-by":"publisher","award":["APQ-01695-1"],"award-info":[{"award-number":["APQ-01695-1"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG\/Brazil","doi-asserted-by":"publisher","award":["PPM-00456-17"],"award-info":[{"award-number":["PPM-00456-17"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.preteyeres.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T16:46:27Z","timestamp":1509468387000},"page":"107-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":392,"special_numbering":"C","title":["Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives"],"prefix":"10.1016","volume":"63","author":[{"given":"Marina Fran\u00e7a","family":"Dias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4266-1491","authenticated-orcid":false,"given":"Kwangsic","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Lig\u00f3rio","family":"Fialho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Armando","family":"da Silva Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3692-7169","authenticated-orcid":false,"given":"Se Joon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jik","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2017.10.004_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/IAE.0b013e31809862aa","article-title":"Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial","volume":"28","author":"Adackapara","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/13816810701537424","article-title":"The retinal ciliopathies","volume":"28","author":"Adams","year":"2007","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3928\/23258160-20140131-03","article-title":"The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review","volume":"45","author":"Ahn","year":"2014","journal-title":"Ophthalmic Surg. lasers imaging retina"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cell.2015.03.023","article-title":"Rod-derived cone viability factor promotes cone survival by stimulating aerobic glycolysis","volume":"161","author":"Ait-Ali","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib5","first-page":"1873","article-title":"Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome","volume":"42","author":"Aleman","year":"2001","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/77068","article-title":"Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy","volume":"25","author":"Ali","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib7","doi-asserted-by":"crossref","first-page":"11372","DOI":"10.1128\/JVI.01327-07","article-title":"Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors","volume":"81","author":"Allocca","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/jop.2009.0089","article-title":"Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa","volume":"25","author":"Artunay","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.stemcr.2014.03.011","article-title":"Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice","volume":"2","author":"Assawachananont","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib10","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.febslet.2013.05.020","article-title":"The cell stress machinery and retinal degeneration","volume":"587","author":"Athanasiou","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib11","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/hmg\/10.26.3075","article-title":"Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model","volume":"10","author":"Auricchio","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib12","doi-asserted-by":"crossref","first-page":"e115239","DOI":"10.1371\/journal.pone.0115239","article-title":"First-in-human trial of a novel suprachoroidal retinal prosthesis","volume":"9","author":"Ayton","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib13","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber's congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib14","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib15","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib16","doi-asserted-by":"crossref","first-page":"19969","DOI":"10.1038\/srep19969","article-title":"Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells","volume":"6","author":"Bassuk","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib17","doi-asserted-by":"crossref","first-page":"e1005811","DOI":"10.1371\/journal.pgen.1005811","article-title":"In vivo analysis of disease-associated point mutations unveils profound differences in mRNA splicing of Peripherin-2 in rod and cone photoreceptors","volume":"12","author":"Becirovic","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib18","doi-asserted-by":"crossref","first-page":"E5844","DOI":"10.1073\/pnas.1509914112","article-title":"Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease","volume":"112","author":"Beltran","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.mt.6300389","article-title":"Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer","volume":"16","author":"Bennicelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.preteyeres.2010.03.004","article-title":"The molecular basis of human retinal and vitreoretinal diseases","volume":"29","author":"Berger","year":"2010","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archopht.1993.01090060049022","article-title":"A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa","volume":"111","author":"Berson","year":"1993","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/archophthalmol.2010.32","article-title":"Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A","volume":"128","author":"Berson","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archopht.122.9.1297","article-title":"Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment","volume":"122","author":"Berson","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib25","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/archopht.122.9.1306","article-title":"Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses","volume":"122","author":"Berson","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib26","first-page":"3027","article-title":"Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations","volume":"43","author":"Berson","year":"2002","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0002-9394(85)90351-4","article-title":"Natural course of retinitis pigmentosa over a three-year interval","volume":"99","author":"Berson","year":"1985","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/bjophthalmol-2013-303084","article-title":"Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid","volume":"97","author":"Bhalla","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0161-6420(99)90064-7","article-title":"Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy","volume":"106","author":"Birch","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2016.07.013","article-title":"Long-term follow-up of patients with retinitis pigmentosa receiving intraocular ciliary neurotrophic factor implants","volume":"170","author":"Birch","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajo.2013.03.021","article-title":"Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa","volume":"156","author":"Birch","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.preteyeres.2008.01.002","article-title":"The spectrum of retinal dystrophies caused by mutations in the peripherin\/RDS gene","volume":"27","author":"Boon","year":"2008","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib33","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1167\/iovs.02-1068","article-title":"Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles","volume":"44","author":"Bourges","year":"2003","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib34","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nbt.3003","article-title":"The special case of gene therapy pricing","volume":"32","author":"Brennan","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2017.03.003","article-title":"Unravelling the genetics of inherited retinal dystrophies: past, present and future","volume":"59","author":"Broadgate","year":"2017","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/156652307782793531","article-title":"Neuroprotective gene therapy for the treatment of inherited retinal degeneration","volume":"7","author":"Buch","year":"2007","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib37","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ymthe.2006.05.019","article-title":"In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration","volume":"14","author":"Buch","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib38","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ymthe.2017.05.015","article-title":"Using CRISPR-Cas9 to generate gene-corrected autologous iPSCs for the treatment of inherited retinal degeneration","volume":"25","author":"Burnight","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.1190897","article-title":"Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa","volume":"329","author":"Busskamp","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.exer.2008.09.018","article-title":"Effect of shape and coating of a subretinal prosthesis on its integration with the retina","volume":"88","author":"Butterwick","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib41","first-page":"264","article-title":"The synthetic progestin norgestrel acts to increase LIF levels in the rd10 mouse model of retinitis pigmentosa","volume":"22","author":"Byrne","year":"2016","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1172\/JCI65654","article-title":"Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration","volume":"125","author":"Byrne","year":"2015","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/13816810802626399","article-title":"RPE65: role in the visual cycle, human retinal disease, and gene therapy","volume":"30","author":"Cai","year":"2009","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib44","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1096\/fj.09-139147","article-title":"Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa","volume":"24","author":"Cai","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1001\/archophthalmol.2009.20","article-title":"Feasibility study of a retinal prosthesis: spatial vision with a 16-electrode implant","volume":"127","author":"Caspi","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib46","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.cub.2015.07.029","article-title":"Restoration of vision with ectopic expression of human rod opsin","volume":"25","author":"Cehajic-Kapetanovic","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/mt.2008.301","article-title":"Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy","volume":"17","author":"Chadderton","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib48","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.brainres.2016.04.021","article-title":"Endoplasmic reticulum stress in human photoreceptor diseases","volume":"1648","author":"Chan","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0896-6273(93)90072-Y","article-title":"Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice","volume":"11","author":"Chang","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib50","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1471-4159.2000.0721327.x","article-title":"The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3","volume":"72","author":"Chen","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2007.06.053","article-title":"Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity","volume":"149","author":"Chen","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib52","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1167\/iovs.05-0965","article-title":"RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65-\/- mice","volume":"47","author":"Chen","year":"2006","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib53","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/archopht.122.4.460","article-title":"The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa","volume":"122","author":"Chow","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib54","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.preteyeres.2010.04.002","article-title":"Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy","volume":"29","author":"Cideciyan","year":"2010","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib55","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/hum.2009.086","article-title":"Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year","volume":"20","author":"Cideciyan","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bjo.2009.175356","article-title":"Therapeutic potential of valproic acid for retinitis pigmentosa","volume":"95","author":"Clemson","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib57","first-page":"560","article-title":"[Gene therapy for inherited retinal dystrophies]","volume":"72","author":"Coco","year":"2009","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib58","first-page":"832","article-title":"Some cytological and initial biochemical observations on photoreceptors in retinas of rds mice","volume":"24","author":"Cohen","year":"1983","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/humc.2013.037","article-title":"Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa","volume":"24","author":"Conlon","year":"2013","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib61","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archopht.1988.01060140350030","article-title":"Treatment of chronic macular edema with acetazolamide","volume":"106","author":"Cox","year":"1988","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2014.07.001","article-title":"Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases","volume":"43","author":"Cuenca","year":"2014","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib63","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib64","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/hum.2015.147","article-title":"Let there Be light: gene and cell therapy for blindness","volume":"27","author":"Dalkara","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib65","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/mt.2009.181","article-title":"Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous","volume":"17","author":"Dalkara","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.crvi.2014.01.002","article-title":"Gene therapy for inherited retinal degenerations","volume":"337","author":"Dalkara","year":"2014","journal-title":"C R. Biol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/geno.1995.0001","article-title":"Mutations in the PDE6B gene in autosomal recessive retinitis pigmentosa","volume":"30","author":"Danciger","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib68","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1093\/hmg\/11.25.3209","article-title":"Disease mechanism for retinitis pigmentosa (RP11) caused by mutations in the splicing factor gene PRPF31","volume":"11","author":"Deery","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.preteyeres.2008.05.003","article-title":"Leber congenital amaurosis: genes, proteins and disease mechanisms","volume":"27","author":"den Hollander","year":"2008","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib70","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/hum.2005.16.649","article-title":"Adeno-associated virus-vectored gene therapy for retinal disease","volume":"16","author":"Dinculescu","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib71","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1471-4159.2011.07354.x","article-title":"Enhancing survival of photoreceptor cells in vivo using the synthetic progestin Norgestrel","volume":"118","author":"Doonan","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib72","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/mt.2011.69","article-title":"Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness","volume":"19","author":"Doroudchi","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib73","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1167\/iovs.11-8544","article-title":"TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice","volume":"53","author":"Drack","year":"2012","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib74","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.neuroscience.2006.02.065","article-title":"Valproic acid induces caspase 3-mediated apoptosis in microglial cells","volume":"140","author":"Dragunow","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib75","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ICU.0000000000000140","article-title":"Optogenetics","volume":"26","author":"Duebel","year":"2015","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib76","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/IAE.0b013e31821e2070","article-title":"Rasagiline interferes with neurodegeneration in the Prph2\/rds mouse","volume":"32","author":"Eigeldinger-Berthou","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib77","series-title":"GeneReviews(R), Seattle (WA)","article-title":"Nonsyndromic retinitis pigmentosa overview","author":"Fahim","year":"1993"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib78","series-title":"GeneReviews(R), Seattle (WA)","article-title":"Retinitis pigmentosa overview","author":"Fahim","year":"1993"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib79","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1089\/hum.2012.067","article-title":"Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosa","volume":"23","author":"Fernandez-Sanchez","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib80","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/138920211795860107","article-title":"Retinitis pigmentosa: genes and disease mechanisms","volume":"12","author":"Ferrari","year":"2011","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0163-7827(83)90004-8","article-title":"Chemistry and metabolism of lipids in the vertebrate retina","volume":"22","author":"Fliesler","year":"1983","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib82","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ejhg.2012.115","article-title":"Bardet-Biedl syndrome","volume":"21","author":"Forsythe","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"issue":"Suppl 3","key":"10.1016\/j.preteyeres.2017.10.004_bib83","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1177\/112067210301303S08","article-title":"Pharmacological strategies to block rod photoreceptor apoptosis caused by calcium overload: a mechanistic target-site approach to neuroprotection","volume":"13","author":"Fox","year":"2003","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib84","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/13508","article-title":"Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse","volume":"5","author":"Frasson","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib85","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1167\/iovs.10-6836","article-title":"Testing of semichronically implanted retinal prosthesis by suprachoroidal-transretinal stimulation in patients with retinitis pigmentosa","volume":"52","author":"Fujikado","year":"2011","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib86","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1073\/pnas.042122399","article-title":"Progressive photoreceptor degeneration, outer segment dysplasia, and rhodopsin mislocalization in mice with targeted disruption of the retinitis pigmentosa-1 (Rp1) gene","volume":"99","author":"Gao","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib87","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1167\/iovs.08-2831","article-title":"Photoreceptor neuroprotection in RCS rats via low-dose intravitreal sustained-delivery of fluocinolone acetonide","volume":"50","author":"Glybina","year":"2009","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib88","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1073\/pnas.0911991107","article-title":"Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP\/Grp78","volume":"107","author":"Gorbatyuk","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib89","first-page":"784","article-title":"Retinitis pigmentosa in abetalipoproteinemia: effects of vitamin A","volume":"10","author":"Gouras","year":"1971","journal-title":"Invest Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib90","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2005.12.030","article-title":"Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa","volume":"141","author":"Grover","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib91","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0161-6420(97)30291-7","article-title":"Rate of visual field loss in retinitis pigmentosa","volume":"104","author":"Grover","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib92","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.preteyeres.2015.06.005","article-title":"Pharmacological approaches to retinitis pigmentosa: a laboratory perspective","volume":"48","author":"Guadagni","year":"2015","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib93","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/08820538.2015.1114856","article-title":"Course of ocular function in PRPF31 retinitis pigmentosa","volume":"31","author":"Hafler","year":"2016","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib94","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/bjo.2008.138560","article-title":"The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography","volume":"92","author":"Hajali","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib95","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-1-40","article-title":"Retinitis pigmentosa","volume":"1","author":"Hamel","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib96","first-page":"2579","article-title":"Review: the history and role of naturally occurring mouse models with Pde6b mutations","volume":"19","author":"Han","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib97","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib98","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.preteyeres.2006.07.002","article-title":"Gene therapy and transplantation in CNS repair: the visual system","volume":"25","author":"Harvey","year":"2006","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib99","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/mcne.2002.1168","article-title":"Intravitreal injection of adeno-associated viral vectors results in the transduction of different types of retinal neurons in neonatal and adult rats: a comparison with lentiviral vectors","volume":"21","author":"Harvey","year":"2002","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib101","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrn.2015.2","article-title":"Applications of CRISPR-Cas systems in neuroscience","volume":"17","author":"Heidenreich","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib102","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000072042","article-title":"Retinitis pigmentosa: genes, proteins and prospects","volume":"37","author":"Hims","year":"2003","journal-title":"Dev. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib103","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2015.04.032","article-title":"Long-term results from an epiretinal prosthesis to restore Sight to the blind","volume":"122","author":"Ho","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib104","first-page":"704","article-title":"A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa","volume":"137","author":"Hoffman","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib105","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1021\/acsnano.6b04155","article-title":"Viral\/nonviral chimeric nanoparticles to synergistically suppress leukemia proliferation via simultaneous gene transduction and silencing","volume":"10","author":"Hong","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib106","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0042-6989(99)00052-8","article-title":"Pattern electrical stimulation of the human retina","volume":"39","author":"Humayun","year":"1999","journal-title":"Vis. Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib107","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ophtha.2011.09.028","article-title":"Interim results from the international trial of Second Sight's visual prosthesis","volume":"119","author":"Humayun","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib108","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/S0042-6989(03)00457-7","article-title":"Visual perception in a blind subject with a chronic microelectronic retinal prosthesis","volume":"43","author":"Humayun","year":"2003","journal-title":"Vis. Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2016.05.001","article-title":"Genome engineering in ophthalmology: application of CRISPR\/Cas to the treatment of eye disease","volume":"53","author":"Hung","year":"2016","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib110","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bjophthalmol-2012-303005","article-title":"Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa","volume":"97","author":"Ikeda","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib111","doi-asserted-by":"crossref","first-page":"34150","DOI":"10.1074\/jbc.M204955200","article-title":"A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system","volume":"277","author":"Illing","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib112","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2147\/OPTH.S109995","article-title":"Efficacy of valproic acid for retinitis pigmentosa patients: a pilot study","volume":"10","author":"Iraha","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib113","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1167\/iovs.10-5389","article-title":"Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina","volume":"51","author":"Ivanova","year":"2010","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib114","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ymthe.2006.03.005","article-title":"Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection","volume":"13","author":"Jacobson","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib115","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","article-title":"Improvement and decline in vision with gene therapy in childhood blindness","volume":"372","author":"Jacobson","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib116","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.preteyeres.2015.01.003","article-title":"Cellular strategies for retinal repair by photoreceptor replacement","volume":"46","author":"Jayakody","year":"2015","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib117","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib118","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s12272-010-1007-6","article-title":"How to overcome retinal neuropathy: the fight against angiogenesis-related blindness","volume":"33","author":"Jo","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib119","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.exer.2016.03.018","article-title":"Retinal remodeling in human retinitis pigmentosa","volume":"150","author":"Jones","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.10703","article-title":"Retinal remodeling triggered by photoreceptor degenerations","volume":"464","author":"Jones","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.01.004","article-title":"Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases","volume":"58","author":"Jones","year":"2017","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib122","doi-asserted-by":"crossref","first-page":"e62097","DOI":"10.1371\/journal.pone.0062097","article-title":"Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors","volume":"8","author":"Kay","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib123","first-page":"216","article-title":"Redundant safety features in a high-channel-count retinal neurostimulator","volume":"2014","author":"Kelly","year":"2014","journal-title":"IEEE Biomed. Circuits Syst. Conf."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib124","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tig.2004.12.001","article-title":"Light in retinitis pigmentosa","volume":"21","author":"Kennan","year":"2005","journal-title":"Trends Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/13816810.2011.642453","article-title":"Association of p.P347L in the rhodopsin gene with early-onset cystoid macular edema in patients with retinitis pigmentosa","volume":"33","author":"Kim","year":"2012","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib126","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/01.iae.0000254897.86389.a5","article-title":"Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa","volume":"26","author":"Kim","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib127","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1167\/iovs.12-10149","article-title":"Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa","volume":"54","author":"Kim","year":"2013","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib128","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1093\/hmg\/dds290","article-title":"Gene therapy restores vision and delays degeneration in the CNGB1(-\/-) mouse model of retinitis pigmentosa","volume":"21","author":"Koch","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib129","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.1016\/j.biomaterials.2013.06.002","article-title":"A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium","volume":"34","author":"Koirala","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.survophthal.2013.09.004","article-title":"Trophic factors in the pathogenesis and therapy for retinal degenerative diseases","volume":"59","author":"Kolomeyer","year":"2014","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib131","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/hum.2009.194","article-title":"Changes in adeno-associated virus-mediated gene delivery in retinal degeneration","volume":"21","author":"Kolstad","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib132","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","article-title":"The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection","volume":"33","author":"Koo","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib133","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1089\/jop.2013.0166","article-title":"Efficacy of oral valproic acid in patients with retinitis pigmentosa","volume":"30","author":"Kumar","year":"2014","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib134","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJMoa1609583","article-title":"Vision loss after intravitreal injection of autologous \"stem cells\" for AMD","volume":"376","author":"Kuriyan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.preteyeres.2013.06.001","article-title":"Evolution of phototransduction, vertebrate photoreceptors and retina","volume":"36","author":"Lamb","year":"2013","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib136","doi-asserted-by":"crossref","first-page":"e8763","DOI":"10.1371\/journal.pone.0008763","article-title":"Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells","volume":"5","author":"Lamba","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib137","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jgm.1126","article-title":"Novel AAV serotypes for improved ocular gene transfer","volume":"10","author":"Lebherz","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib138","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0140-6736(17)31622-7","article-title":"Gene therapy for RPE65-mediated inherited retinal dystrophy completes phase 3","volume":"390","author":"Lee","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib139","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1021\/acs.molpharmaceut.6b00148","article-title":"Anti-vegf PolysiRNA polyplex for the treatment of choroidal neovascularization","volume":"13","author":"Lee","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib140","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/jcp.22508","article-title":"N-Acetylcysteine promotes long-term survival of cones in a model of retinitis pigmentosa","volume":"226","author":"Lee","year":"2011","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib141","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1371\/journal.pone.0000314","article-title":"XIAP protection of photoreceptors in animal models of retinitis pigmentosa","volume":"2","author":"Leonard","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib142","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ng1386","article-title":"Identification and characterization of rod-derived cone viability factor","volume":"36","author":"Leveillard","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib143","first-page":"1760","article-title":"Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential","volume":"14","author":"Li","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib144","doi-asserted-by":"crossref","first-page":"11933","DOI":"10.1073\/pnas.95.20.11933","article-title":"Effect of vitamin A supplementation on rhodopsin mutants threonine-17--> methionine and proline-347--> serine in transgenic mice and in cell cultures","volume":"95","author":"Li","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib145","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2119\/molmed.2012.00242","article-title":"Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa","volume":"18","author":"Li","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib146","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/mthe.2001.0473","article-title":"Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa","volume":"4","author":"Liang","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib147","doi-asserted-by":"crossref","first-page":"16009","DOI":"10.1073\/pnas.0806114105","article-title":"Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin","volume":"105","author":"Lin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib148","doi-asserted-by":"crossref","first-page":"e111754","DOI":"10.1371\/journal.pone.0111754","article-title":"Identification of a PRPF4 loss-of-function variant that abrogates U4\/U6.U5 tri-snRNP integration and is associated with retinitis pigmentosa","volume":"9","author":"Linder","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib149","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/13816810.2015.1101775","article-title":"Macular cystoid spaces in patients with retinal dystrophy","volume":"37","author":"Lingao","year":"2016","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib150","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/mt.2015.68","article-title":"CNTF gene therapy Confers lifelong neuroprotection in a mouse model of human retinitis pigmentosa","volume":"23","author":"Lipinski","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib151","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.preteyeres.2012.09.001","article-title":"Clinical applications of retinal gene therapy","volume":"32","author":"Lipinski","year":"2013","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib152","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1089\/104303403322542301","article-title":"Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina","volume":"14","author":"Lotery","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib153","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.preteyeres.2015.09.003","article-title":"The Argus((R)) II retinal prosthesis system","volume":"50","author":"Luo","year":"2016","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib154","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.ophtha.2016.06.041","article-title":"Gene therapy and stem cell transplantation in retinal disease: the new frontier","volume":"123","author":"MacLaren","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib155","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"MacLaren","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib156","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib157","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib158","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.stemcr.2016.12.008","article-title":"iPSC-derived retina transplants improve vision in rd1 end-stage retinal-degeneration mice","volume":"8","author":"Mandai","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib159","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell-derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib160","article-title":"Intravitreal dexamethasone implant in retinitis pigmentosa-related cystoid macular edema","author":"Mansour","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib161","doi-asserted-by":"crossref","first-page":"e24245","DOI":"10.1371\/journal.pone.0024245","article-title":"Tauroursodeoxycholic acid (TUDCA) protects photoreceptors from cell death after experimental retinal detachment","volume":"6","author":"Mantopoulos","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib162","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/hum.2010.140","article-title":"AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa","volume":"22","author":"Mao","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib163","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1350-9462(03)00039-9","article-title":"Neural remodeling in retinal degeneration","volume":"22","author":"Marc","year":"2003","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib164","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archophthalmol.2010.46","article-title":"How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa?","volume":"128","author":"Massof","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nphoton.2012.104","article-title":"Photovoltaic retinal prosthesis with high pixel density","volume":"6","author":"Mathieson","year":"2012","journal-title":"Nat. Photonics"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib166","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1167\/iovs.11-8372","article-title":"Autosomal dominant retinitis pigmentosa with intrafamilial variability and incomplete penetrance in two families carrying mutations in PRPF8","volume":"52","author":"Maubaret","year":"2011","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib167","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.scr.2015.02.003","article-title":"Stem cell treatment of degenerative eye disease","volume":"14","author":"Mead","year":"2015","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib168","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molmed.2005.02.007","article-title":"Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy","volume":"11","author":"Mendes","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib169","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mt.2010.293","article-title":"Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa","volume":"19","author":"Millington-Ward","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib170","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2009.10.042","article-title":"Antioxidants rescue photoreceptors in rd1 mice: relationship with thiol metabolism","volume":"48","author":"Miranda","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib171","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1073\/pnas.94.19.10319","article-title":"Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector","volume":"94","author":"Miyoshi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib172","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1073\/pnas.95.6.3088","article-title":"Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis","volume":"95","author":"Morimura","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib173","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12886-015-0033-z","article-title":"Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa - a first case report and short review of the literature","volume":"15","author":"Moustafa","year":"2015","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib1a","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.preteyeres.2013.08.001","article-title":"Photoreceptor cell death and rescue in retinal detachment and degenerations","volume":"37","author":"Murakami","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib174","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1167\/iovs.14-15962","article-title":"TUDCA promotes phagocytosis by retinal pigment epithelium via MerTK activation","volume":"56","author":"Murase","year":"2015","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajo.2017.01.014","article-title":"Prevalence, age at diagnosis, mortality, and cause of death in retinitis pigmentosa in Korea-a nationwide population-based study","volume":"176","author":"Na","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib176","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000320500","article-title":"Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial","volume":"225","author":"Nakazawa","year":"2011","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib177","doi-asserted-by":"crossref","first-page":"585729","DOI":"10.1155\/2013\/585729","article-title":"Long-term effects of nilvadipine against progression of the central visual field defect in retinitis pigmentosa: an extended study","volume":"2013","author":"Nakazawa","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib178","first-page":"139","article-title":"Retinal dystrophies, genomic applications in diagnosis and prospects for therapy","volume":"4","author":"Nash","year":"2015","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib179","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-4835(05)80218-0","article-title":"Changes in the DC electroretinogram in Briard dogs with hereditary congenital night blindness and partial day blindness","volume":"54","author":"Nilsson","year":"1992","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib180","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.visres.2007.08.014","article-title":"A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa","volume":"48","author":"O'Reilly","year":"2008","journal-title":"Vis. Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib181","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s11095-013-1271-5","article-title":"A novel formulation based on 2,3-di(tetradecyloxy)propan-1-amine cationic lipid combined with polysorbate 80 for efficient gene delivery to the retina","volume":"31","author":"Ochoa","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib182","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1167\/iovs.14-15458","article-title":"Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing","volume":"55","author":"Oishi","year":"2014","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib183","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3109\/02713683.2014.907430","article-title":"Protection of cone photoreceptor M-opsin degradation with 9-cis-beta-carotene-rich alga Dunaliella bardawil in Rpe65(-\/-) mouse retinal explant culture","volume":"39","author":"Ozaki","year":"2014","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib184","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev.biochem.75.103004.142743","article-title":"G protein-coupled receptor rhodopsin","volume":"75","author":"Palczewski","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.exer.2004.03.010","article-title":"Adenoviral-mediated gene transfer to retinal explants during development and degeneration","volume":"79","author":"Pang","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib186","first-page":"152","article-title":"Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA)","volume":"11","author":"Pang","year":"2005","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib187","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1471-4159.2010.06983.x","article-title":"Photoreceptor rescue and toxicity induced by different calpain inhibitors","volume":"115","author":"Paquet-Durand","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib188","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1167\/iovs.16-19204","article-title":"Intraocular pharmacokinetics of intravitreal aflibercept (Eylea) in a Rabbit model","volume":"57","author":"Park","year":"2016","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib189","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1167\/iovs.14-15415","article-title":"Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings","volume":"56","author":"Park","year":"2014","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib190","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/gt.2009.61","article-title":"Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse","volume":"16","author":"Park","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib191","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/gt.2015.93","article-title":"Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosa","volume":"23","author":"Pawlyk","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib192","first-page":"1912","article-title":"Absence of photoreceptor rescue with D-cis-diltiazem in the rd mouse","volume":"43","author":"Pawlyk","year":"2002","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib193","first-page":"42","article-title":"Calcium channel blocker D-cis-diltiazem does not slow retinal degeneration in the PDE6B mutant rcd1 canine model of retinitis pigmentosa","volume":"7","author":"Pearce-Kelling","year":"2001","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib194","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.preteyeres.2013.03.002","article-title":"Protein sorting, targeting and trafficking in photoreceptor cells","volume":"36","author":"Pearring","year":"2013","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib195","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.nano.2016.06.007","article-title":"Span poly-L-arginine nanoparticles are efficient non-viral vectors for PRPF31 gene delivery: an approach of gene therapy to treat retinitis pigmentosa","volume":"12","author":"Pensado","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib196","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj20021596","article-title":"Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3","volume":"372","author":"Perez","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib197","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1167\/iovs.16-21041","article-title":"Determining the Contribution of Retinotopic Discrimination to Localization Performance With a Suprachoroidal Retinal Prosthesis","volume":"58","author":"Petoe","year":"2017","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib198","first-page":"127","article-title":"Advances in gene therapy technologies to treat retinitis pigmentosa","volume":"8","author":"Petrs-Silva","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib199","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/ejn.12196","article-title":"Cone survival and preservation of visual acuity in an animal model of retinal degeneration","volume":"37","author":"Piano","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib2a","doi-asserted-by":"crossref","first-page":"e0136523","DOI":"10.1371\/journal.pone.0136523","article-title":"Trans-corneal subretinal injection in mice and its effect on the function and morphology of the retina","volume":"10","author":"Qi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib200","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1021\/nl502275s","article-title":"Nanoparticle-assisted targeted delivery of eye-specific genes to eyes significantly improves the vision of blind mice in vivo","volume":"14","author":"Rajala","year":"2014","journal-title":"Nano Lett."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib201","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s10495-009-0341-y","article-title":"Cellular responses to endoplasmic reticulum stress and apoptosis","volume":"14","author":"Rasheva","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0304-3940(84)90024-7","article-title":"Development and degeneration of retina in rds mutant mice: the electroretinogram","volume":"48","author":"Reuter","year":"1984","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib203","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/WNO.0b013e31821eb79e","article-title":"Update on retinal prosthetic research: the boston retinal implant project","volume":"31","author":"Rizzo","year":"2011","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib204","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1167\/iovs.02-0817","article-title":"Perceptual efficacy of electrical stimulation of human retina with a microelectrode array during short-term surgical trials","volume":"44","author":"Rizzo","year":"2003","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib205","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1167\/iovs.08-2752","article-title":"Implantation and explantation of a wireless epiretinal retina implant device: observations during the EPIRET3 prospective clinical trial","volume":"50","author":"Roessler","year":"2009","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib206","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1167\/iovs.02-0567","article-title":"Correlation of regenerable opsin with rod ERG signal in Rpe65-\/- mice during development and aging","volume":"44","author":"Rohrer","year":"2003","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib207","first-page":"2479","article-title":"Gene therapy in animal models of autosomal dominant retinitis pigmentosa","volume":"18","author":"Rossmiller","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib208","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib209","doi-asserted-by":"crossref","first-page":"737053","DOI":"10.1155\/2015\/737053","article-title":"Systematic review of randomized clinical trials on safety and efficacy of pharmacological and nonpharmacological treatments for retinitis pigmentosa","volume":"2015","author":"Sacchetti","year":"2015","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib210","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-neuro-062012-170304","article-title":"Gene therapy for blindness","volume":"36","author":"Sahel","year":"2013","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib211","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/138920211795860062","article-title":"Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy","volume":"12","author":"Sahni","year":"2011","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib212","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/jop.2010.0044","article-title":"Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa","volume":"26","author":"Salom","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib213","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.phrs.2015.06.019","article-title":"Neuroprotective actions of progesterone in an in vivo model of retinitis pigmentosa","volume":"99","author":"Sanchez-Vallejo","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib214","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/bjo.2010.198176","article-title":"Lack of scientific rationale for use of valproic acid for retinitis pigmentosa","volume":"95","author":"Sandberg","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib3a","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.4.5.5","article-title":"Prenatal exposure to curcumin protects rod photoreceptors in a transgenic Pro23His swine model of retinitis pigmentosa","volume":"4","author":"Scott","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib216","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.preteyeres.2012.06.003","article-title":"Cell replacement and visual restoration by retinal sheet transplants","volume":"31","author":"Seiler","year":"2012","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib217","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s40123-012-0006-8","article-title":"Effect of short-term oral valproic Acid on vision and visual field in retinitis pigmentosa","volume":"1","author":"Shanmugam","year":"2012","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib218","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/jop.2008.0013","article-title":"Resveratrol and large-conductance calcium-activated potassium channels in the protection of human retinal pigment epithelial cells","volume":"24","author":"Sheu","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib219","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.optm.2008.01.026","article-title":"Review and update: current treatment trends for patients with retinitis pigmentosa","volume":"80","author":"Shintani","year":"2009","journal-title":"Optometry"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib220","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1073\/pnas.1512590113","article-title":"Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration","volume":"113","author":"Shirai","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib221","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.0600236103","article-title":"Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants","volume":"103","author":"Sieving","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib222","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13287-015-0020-6","article-title":"Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell -clinical trial)","volume":"6","author":"Siqueira","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib223","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/IAE.0b013e3181f9c242","article-title":"Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial","volume":"31","author":"Siqueira","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib224","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/bjophthalmol-2012-301950","article-title":"Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa","volume":"96","author":"Sisk","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.preteyeres.2015.04.004","article-title":"The pros and cons of vertebrate animal models for functional and therapeutic research on inherited retinal dystrophies","volume":"48","author":"Slijkerman","year":"2015","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib226","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S1525-0016(03)00144-8","article-title":"AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa","volume":"8","author":"Smith","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib227","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.visres.2015.03.001","article-title":"Subretinal visual implant alpha IMS\u2013clinical trial interim report","volume":"111","author":"Stingl","year":"2015","journal-title":"Vis. Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib228","doi-asserted-by":"crossref","first-page":"18706","DOI":"10.1073\/pnas.1007644107","article-title":"Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa","volume":"107","author":"Strettoi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib229","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.preteyeres.2015.12.002","article-title":"PRPH2\/RDS and ROM-1: historical context, current views and future considerations","volume":"52","author":"Stuck","year":"2016","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib230","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/bjophthalmol-2015-307698","article-title":"RPGR-associated retinopathy: clinical features, molecular genetics, animal models and therapeutic options","volume":"100","author":"Tee","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib231","first-page":"3538","article-title":"Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail","volume":"43","author":"Thomson","year":"2002","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib232","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.preteyeres.2014.08.001","article-title":"Vector platforms for gene therapy of inherited retinopathies","volume":"43","author":"Trapani","year":"2014","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib233","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2174\/156652412800620048","article-title":"Neuroprotective strategies for the treatment of inherited photoreceptor degeneration","volume":"12","author":"Trifunovic","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib234","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.gt.3302460","article-title":"Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy","volume":"12","author":"Tschernutter","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib235","first-page":"2693","article-title":"Apoptosis leads to photoreceptor degeneration in inherited retinal dystrophy of RCS rats","volume":"35","author":"Tso","year":"1994","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib236","first-page":"3556","article-title":"Unoprostone reduces oxidative stress- and light-induced retinal cell death, and phagocytotic dysfunction, by activating BK channels","volume":"17","author":"Tsuruma","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib237","doi-asserted-by":"crossref","first-page":"e18992","DOI":"10.1371\/journal.pone.0018992","article-title":"Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice","volume":"6","author":"Tucker","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib238","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/glia.22617","article-title":"AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers","volume":"62","author":"Vacca","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib239","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0039-6257(98)00046-0","article-title":"Retinitis pigmentosa: defined from a molecular point of view","volume":"43","author":"van Soest","year":"1999","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib240","doi-asserted-by":"crossref","first-page":"e21193","DOI":"10.1371\/journal.pone.0021193","article-title":"Rescue of photoreceptor degeneration by curcumin in transgenic rats with P23H rhodopsin mutation","volume":"6","author":"Vasireddy","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib241","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1242\/dmm.017913","article-title":"Biology and therapy of inherited retinal degenerative disease: insights from mouse models","volume":"8","author":"Veleri","year":"2015","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib242","first-page":"913","article-title":"Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization","volume":"10","author":"Vinores","year":"1995","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib243","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1167\/iovs.03-0253","article-title":"Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular clue for incomplete penetrance?","volume":"44","author":"Vithana","year":"2003","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib244","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1073\/pnas.221364198","article-title":"Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk","volume":"98","author":"Vollrath","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib245","doi-asserted-by":"crossref","first-page":"21587","DOI":"10.1038\/srep21587","article-title":"Efficacy and safety of rAAV2-ND4 treatment for Leber's hereditary optic neuropathy","volume":"6","author":"Wan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib246","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1038\/srep07601","article-title":"Retinal structure and function preservation by polysaccharides of wolfberry in a mouse model of retinal degeneration","volume":"4","author":"Wang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib247","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1167\/iovs.06-0963","article-title":"Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa","volume":"48","author":"Waseem","year":"2007","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib248","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1350-9462(02)00037-X","article-title":"Survival and axonal regeneration of retinal ganglion cells in adult cats","volume":"21","author":"Watanabe","year":"2002","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib249","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00467-010-1731-7","article-title":"Ciliopathies: an expanding disease spectrum","volume":"26","author":"Waters","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib250","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1525-0016(03)00098-4","article-title":"Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery","volume":"7","author":"Weber","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib251","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1109\/TBME.2014.2314733","article-title":"Retinal prosthesis","volume":"61","author":"Weiland","year":"2014","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib252","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4161\/org.26710","article-title":"The role of primary cilia in the development and disease of the retina","volume":"10","author":"Wheway","year":"2014","journal-title":"Organogenesis"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib253","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003707","article-title":"Spliceosome structure and function","volume":"3","author":"Will","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib254","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40123-012-0005-9","article-title":"Topical isopropyl unoprostone for retinitis pigmentosa: microperimetric results of the phase 2 clinical study","volume":"1","author":"Yamamoto","year":"2012","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib255","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ajo.2007.01.027","article-title":"Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa","volume":"143","author":"Yanai","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib256","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2016.09.001","article-title":"In vivo genome editing as a potential treatment strategy for inherited retinal dystrophies","volume":"56","author":"Yanik","year":"2017","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib257","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.mp.4002099","article-title":"The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons","volume":"14","author":"Yasuda","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib258","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ophtha.2012.07.006","article-title":"Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa","volume":"120","author":"Yoshida","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib259","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.ophtha.2012.07.008","article-title":"Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa","volume":"120","author":"Yoshida","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib260","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1523\/JNEUROSCI.2399-04.2005","article-title":"Mutations in PRPF31 inhibit pre-mRNA splicing of rhodopsin gene and cause apoptosis of retinal cells","volume":"25","author":"Yuan","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib261","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.ophtha.2015.08.008","article-title":"Ten-year follow-up of a blind patient Chronically implanted with epiretinal prosthesis Argus I","volume":"122","author":"Yue","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib262","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.preteyeres.2016.05.002","article-title":"Retinal stimulation strategies to restore vision: fundamentals and systems","volume":"53","author":"Yue","year":"2016","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib263","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/02713680802710692","article-title":"Intravitreal bevacizumab (Avastin) injection in retinitis pigmentosa","volume":"34","author":"Yuzbasioglu","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib264","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ajhg.2009.09.020","article-title":"Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4\/U6 snRNAs","volume":"85","author":"Zhao","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib265","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1517\/14712598.2015.1006192","article-title":"Personalized therapeutic strategies for patients with retinitis pigmentosa","volume":"15","author":"Zheng","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.preteyeres.2017.10.004_bib266","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/stem.637","article-title":"Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina","volume":"29","author":"Zhou","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.preteyeres.2017.10.004_bib267","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jconrel.2015.10.007","article-title":"Non-viral therapeutic approaches to ocular diseases: an overview and future directions","volume":"219","author":"Zulliger","year":"2015","journal-title":"J. Control Release"}],"updated-by":[{"DOI":"10.1016\/j.preteyeres.2018.08.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000}}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946217300526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946217300526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:27:46Z","timestamp":1761172066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946217300526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":270,"alternative-id":["S1350946217300526"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2017.10.004","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}